Tvardi Therapeutics, Inc. (TVRD)
4.37
-0.18
(-3.96%)
USD |
NASDAQ |
Jan 12, 11:36
Tvardi Therapeutics Market Cap: 41.00M for Jan. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 47.61B |
| Novavax, Inc. | 1.196B |
| Precigen, Inc. | 1.504B |
| Xencor, Inc. | 1.005B |
| Denali Therapeutics, Inc. | 2.714B |
Market Cap Related Metrics
| PS Ratio | 5.669 |
| Price to Book Value | 1.471 |
| Price | 4.37 |
| Earnings Yield | -225.5% |